Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe study page now shows that recruitment is no longer open to participants, clarifying that enrollment has ended. The record history reflects a new revision (v3.6.0) replacing the previous v3.5.5.SummaryDifference0.4%

- Check14 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, replacing the previous revision (v3.5.4), reflecting an update to the page's version history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new history entry (version 9) with a Study Status update was added for 2026-05-19, expanding the record’s current-state information. The entry dated 2025-12-23 was removed from the history.SummaryDifference0.4%

- Check36 days agoChange DetectedThe record history now shows a new Revision: v3.5.4, replacing the prior Revision: v3.5.3. This represents a metadata update to the study record's history rather than a change to the study content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page footer’s software revision indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” a change related to the ClinicalTrials.gov site build rather than the underlying study record.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry, v3.5.2, was added to the Record History and the previous v3.5.0 entry was removed.SummaryDifference0.1%

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.